Candel Therapeutics CADL
NASDAQ CADL
$10.16 -0.28 (-2.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Other financing activities (2025)

Updated

Candel Therapeutics' Other financing activities came in at -$178,000 for Q4 2025.

Analysis

Candel Therapeutics (CADL) Other financing activities (2025) Analysis & Trends

For FY2023, Candel Therapeutics' Other financing activities was $121,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Candel Therapeutics 794.67 Mn 794.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -178,000.00
API Access

Candel Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CADL&period=max&api_key=YOUR_API_KEY